Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands
NCT04208100 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2019-12-24
Summary
Prospective, multi-site, non-randomized study of up to 40 treated subjects; subjects enrolled may be greater than subjects treated.
Conditions
- Benign Pigmented Lesions
Interventions
- DEVICE
-
PicoPlus
The PICOPLUS Laser System (K173700) is indicated for use in surgical and aesthetic applications in the medical specialties of dermatology and general and plastic surgery. The 595nm and 660nm wavelengths of the Lutronic PicoPlus Laser system are used for the treatment of benign pigmented lesions.
Sponsors & Collaborators
-
LUTRONIC Corporation
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-13
- Primary Completion
- 2019-09-05
- Completion
- 2020-03-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage
NCT01108523 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Xerotic Dermatitis in Aged People
NCT01806935 ·Status: COMPLETED ·Phase: NA
-
Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
NCT00646867 ·Status: COMPLETED ·Phase: NA
-
Contact Sensitization Potential of 828 Ointment
NCT00767676 ·Status: COMPLETED ·Phase: PHASE1
-
Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis
NCT02823340 ·Status: COMPLETED ·Phase: NA
-
Skin Pathology Assessment With Optical Technologies
NCT04295824 ·Status: COMPLETED
-
Green Banana Peel Extract for Stasis Dermatitis Treatment
NCT06427733 ·Status: COMPLETED ·Phase: PHASE1
-
Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis
NCT04955951 ·Status: TERMINATED
-
A Phase I Clinical Study of Hemay808
NCT04100642 ·Status: COMPLETED ·Phase: PHASE1
-
Sensitization Study of ATx201 in Healthy Volunteers
NCT03375957 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
NCT02700373 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Chilbains Occuring During Covid-19 Infection
NCT04344119 ·Status: UNKNOWN
-
A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria
NCT07181369 ·Status: RECRUITING ·Phase: PHASE1
-
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
NCT03352323 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of Bacitracin
NCT00132600 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis
NCT00643214 ·Status: COMPLETED ·Phase: NA
-
Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies
NCT07228962 ·Status: NOT_YET_RECRUITING
-
A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults
NCT02633371 ·Status: COMPLETED ·Phase: NA
-
A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis
NCT00883311 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions
NCT05270512 ·Status: COMPLETED ·Phase: NA
-
Methotrexat to Hand Eczema in the BIOSKIN Cohort
NCT07338305 ·Status: ACTIVE_NOT_RECRUITING
-
Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous
NCT01429701 ·Status: COMPLETED ·Phase: PHASE3
-
Scratching Validation Study
NCT05137093 ·Status: COMPLETED
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1